Skin Script Blemish Spot Treatment recalled for stability failure
Island Kinetics, Inc. (d.b.a. CoValence Laboratories) is recalling specific lots of Skin Script Blemish Spot Treatment because the product failed stability testing. This means the product may not maintain its intended strength or safety over time. No injuries have been reported.
From the FDA notice · Read the official notice ↗
What to do
- Check if you have lot numbers 4228D2, 4229D1 (expiring 07/31/2026) or 5147D2 (expiring 04/30/2027)
- Stop using the product if you have one of these lots
- Contact Island Kinetics or your retailer for return or refund instructions
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Blemish Spot Treatment (Salicylic Acid) 1%, .5 fl oz (15 ml) bottles, Skin Script, Chandler, AZ 85226, UPC 6 10563 13873 9.
- UPC code
- 610563138739
- Sold in
- Nationwide
- Made for
- Adults (0 months and older)
Details
- Units affected
- 28,163 bottles
- Illnesses reported
- None reported
- Manufactured in
- 460 S Benson Ln Ste 1-3, N/A, Chandler, AZ, United States
- Classification
- Class II
- Recall number
- D-0487-2026
In the FDA's words
- Description
- Blemish Spot Treatment (Salicylic Acid) 1%, .5 fl oz (15 ml) bottles, Skin Script, Chandler, AZ 85226, UPC 6 10563 13873 9. Failed Stability Specifications Lot#: 4228D2, 4229D1, Exp.: 07/31/2026 Lot#: 5147D2, Exp.: 04/30/2027 Distribution: U.S. Nationwide Affected quantity: 28,163 bottles
- Hazard
- Failed Stability Specifications